+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid



Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid



Annals of Neurology 28(1): 12-17



Concentrations of glutamic acid have been reported to be elevated in fasting plasma and cerebrospinal fluid (CSF) of patients with amyotrophic lateral sclerosis (ALS); glycine concentrations have also been reported to be increased in the CSF of such patients. Autopsy studies have shown glutamate contents to be significantly decreased in brain and spinal cord in ALS. These observations suggested that a systemic abnormality of glutamate metabolism might underlie the pathogenesis of ALS. We report here the findings of our studies of amino acid concentrations in patients with the sporadic form of ALS. Glutamate concentrations were normal in the fasting plasma of a great majority of the patients with ALS. Concentrations of glutamate, aspartate, and glycine were normal in the CSF of all 17 patients examined. beta-N-Methylamino-L-alanine, a plant neurotoxin possibly responsible for causing the Guamanian form of ALS, was not detectable in the plasma or CSF of any of our patients. Our findings do not lend support to the hypothesis that the sporadic form of ALS results from overexcitation of motor neurons by excitatory amino acids.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 007005174

Download citation: RISBibTeXText

PMID: 2375629

DOI: 10.1002/ana.410280105


Related references

Amino acid concentration in the cerebrospinal fluid in amyotrophic lateral sclerosis. Medical Science Research 21(15): 561-562, 1993

Free amino acid pattern of cerebrospinal fluid in amyotrophic lateral sclerosis. Acta Neurologica Scandinavica 77(1): 50-53, 1988

Plasma amino acid levels in patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences 107(2): 219-222, 1992

Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: A subtype analysis. Acta Neurologica Scandinavica 88(1): 51-55, 1993

Cerebrospinal fluid amino acids in amyotrophic lateral sclerosis. Annals of Neurology 31(4): 449-450, 1992

Amyotrophic lateral sclerosis: interleukin-6 levels in cerebrospinal fluid. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 19(3): 357-359, 1992

High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients. Acta Neurologica Scandinavica 72(1): 61-64, 1985

Cerebrospinal fluid levels of alpha-tocopherol in amyotrophic lateral sclerosis. Journal of Neural Transmission 105(6-7): 703-708, 1998

Increased serum and cerebrospinal fluid Fgf-2 levels in amyotrophic lateral sclerosis. NeuroReport 14(14): 1867-1869, 2003

Chromogranin A levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Neurobiology of Aging 67: 21-22, 2018

T4, T3 and rT3 levels in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Journal of Neurology 236(1): 57-59, 1989

Increased serum and cerebrospinal fluid FGF-2 levels in amyotrophic lateral sclerosis. Neuroreport 14(14): 1867-1869, 2003

Chromogranin A levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Neurobiology of Aging 67: 21-22, 2018

Manganese in cerebrospinal fluid and blood plasma of patients with amyotrophic lateral sclerosis. Experimental Biology and Medicine 237(7): 803-810, 2012

Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis. Scandinavian Journal of Clinical and Laboratory Investigation 67(3): 264-269, 2007